Journal
BJU INTERNATIONAL
Volume 101, Issue 11, Pages 1339-1342Publisher
WILEY
DOI: 10.1111/j.1464-410X.2008.07506.x
Keywords
clear cell carcinoma; platelet-derived growth factor inhibitor; progression-free survival; RCC; sunitinib; vascular endothelial growth factor inhibitor